↓ Skip to main content

N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer

Overview of attention for article published in Molecular Cancer, August 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer
Published in
Molecular Cancer, August 2021
DOI 10.1186/s12943-021-01398-4
Pubmed ID
Authors

Zhenchuan Liu, Tingting Wang, Yunlang She, Kaiqing Wu, Shaorui Gu, Lei Li, Chenglai Dong, Chang Chen, Yongxin Zhou

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 12%
Other 3 12%
Student > Doctoral Student 3 12%
Student > Bachelor 2 8%
Student > Postgraduate 2 8%
Other 6 24%
Unknown 6 24%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 28%
Unspecified 3 12%
Medicine and Dentistry 3 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Immunology and Microbiology 2 8%
Other 2 8%
Unknown 6 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2021.
All research outputs
#13,410,679
of 21,922,222 outputs
Outputs from Molecular Cancer
#815
of 1,660 outputs
Outputs of similar age
#169,903
of 341,882 outputs
Outputs of similar age from Molecular Cancer
#1
of 1 outputs
Altmetric has tracked 21,922,222 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,660 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,882 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them